Global Prostacyclin Drug Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Page: 91

Published Date: 09 Jan 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

Prostacyclin (also called prostaglandin I2 or PGI2) is a prostaglandin member of the eicosanoid family of lipid molecules. It inhibits platelet activation and is also an effective vasodilator.

According to our (Global Info Research) latest study, the global Prostacyclin Drug market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Prostacyclin Drug market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Prostacyclin Drug market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Prostacyclin Drug market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Prostacyclin Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Prostacyclin Drug market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Prostacyclin Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Prostacyclin Drug market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include United Therapeutics, Actelion (J & J), GSK, Teva and Toray, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation
Prostacyclin Drug market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Epoprostenol Sodium
    Treprostinil
    Iloprost
    Beraprost Sodium

Market segment by Application
    For Injection
    For Oral
    For Inhalation

Major players covered
    United Therapeutics
    Actelion (J & J)
    GSK
    Teva
    Toray
    Tide Pharma
    Bayer AG

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Prostacyclin Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Prostacyclin Drug, with price, sales, revenue and global market share of Prostacyclin Drug from 2018 to 2023.
Chapter 3, the Prostacyclin Drug competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Prostacyclin Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Prostacyclin Drug market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Prostacyclin Drug.
Chapter 14 and 15, to describe Prostacyclin Drug sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Prostacyclin Drug
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Prostacyclin Drug Consumption Value by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Epoprostenol Sodium
        1.3.3 Treprostinil
        1.3.4 Iloprost
        1.3.5 Beraprost Sodium
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Prostacyclin Drug Consumption Value by Application: 2018 Versus 2022 Versus 2029
        1.4.2 For Injection
        1.4.3 For Oral
        1.4.4 For Inhalation
    1.5 Global Prostacyclin Drug Market Size & Forecast
        1.5.1 Global Prostacyclin Drug Consumption Value (2018 & 2022 & 2029)
        1.5.2 Global Prostacyclin Drug Sales Quantity (2018-2029)
        1.5.3 Global Prostacyclin Drug Average Price (2018-2029)

2 Manufacturers Profiles
    2.1 United Therapeutics
        2.1.1 United Therapeutics Details
        2.1.2 United Therapeutics Major Business
        2.1.3 United Therapeutics Prostacyclin Drug Product and Services
        2.1.4 United Therapeutics Prostacyclin Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 United Therapeutics Recent Developments/Updates
    2.2 Actelion (J & J)
        2.2.1 Actelion (J & J) Details
        2.2.2 Actelion (J & J) Major Business
        2.2.3 Actelion (J & J) Prostacyclin Drug Product and Services
        2.2.4 Actelion (J & J) Prostacyclin Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Actelion (J & J) Recent Developments/Updates
    2.3 GSK
        2.3.1 GSK Details
        2.3.2 GSK Major Business
        2.3.3 GSK Prostacyclin Drug Product and Services
        2.3.4 GSK Prostacyclin Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 GSK Recent Developments/Updates
    2.4 Teva
        2.4.1 Teva Details
        2.4.2 Teva Major Business
        2.4.3 Teva Prostacyclin Drug Product and Services
        2.4.4 Teva Prostacyclin Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Teva Recent Developments/Updates
    2.5 Toray
        2.5.1 Toray Details
        2.5.2 Toray Major Business
        2.5.3 Toray Prostacyclin Drug Product and Services
        2.5.4 Toray Prostacyclin Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Toray Recent Developments/Updates
    2.6 Tide Pharma
        2.6.1 Tide Pharma Details
        2.6.2 Tide Pharma Major Business
        2.6.3 Tide Pharma Prostacyclin Drug Product and Services
        2.6.4 Tide Pharma Prostacyclin Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Tide Pharma Recent Developments/Updates
    2.7 Bayer AG
        2.7.1 Bayer AG Details
        2.7.2 Bayer AG Major Business
        2.7.3 Bayer AG Prostacyclin Drug Product and Services
        2.7.4 Bayer AG Prostacyclin Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Bayer AG Recent Developments/Updates

3 Competitive Environment: Prostacyclin Drug by Manufacturer
    3.1 Global Prostacyclin Drug Sales Quantity by Manufacturer (2018-2023)
    3.2 Global Prostacyclin Drug Revenue by Manufacturer (2018-2023)
    3.3 Global Prostacyclin Drug Average Price by Manufacturer (2018-2023)
    3.4 Market Share Analysis (2022)
        3.4.1 Producer Shipments of Prostacyclin Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
        3.4.2 Top 3 Prostacyclin Drug Manufacturer Market Share in 2022
        3.4.2 Top 6 Prostacyclin Drug Manufacturer Market Share in 2022
    3.5 Prostacyclin Drug Market: Overall Company Footprint Analysis
        3.5.1 Prostacyclin Drug Market: Region Footprint
        3.5.2 Prostacyclin Drug Market: Company Product Type Footprint
        3.5.3 Prostacyclin Drug Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Prostacyclin Drug Market Size by Region
        4.1.1 Global Prostacyclin Drug Sales Quantity by Region (2018-2029)
        4.1.2 Global Prostacyclin Drug Consumption Value by Region (2018-2029)
        4.1.3 Global Prostacyclin Drug Average Price by Region (2018-2029)
    4.2 North America Prostacyclin Drug Consumption Value (2018-2029)
    4.3 Europe Prostacyclin Drug Consumption Value (2018-2029)
    4.4 Asia-Pacific Prostacyclin Drug Consumption Value (2018-2029)
    4.5 South America Prostacyclin Drug Consumption Value (2018-2029)
    4.6 Middle East and Africa Prostacyclin Drug Consumption Value (2018-2029)

5 Market Segment by Type
    5.1 Global Prostacyclin Drug Sales Quantity by Type (2018-2029)
    5.2 Global Prostacyclin Drug Consumption Value by Type (2018-2029)
    5.3 Global Prostacyclin Drug Average Price by Type (2018-2029)

6 Market Segment by Application
    6.1 Global Prostacyclin Drug Sales Quantity by Application (2018-2029)
    6.2 Global Prostacyclin Drug Consumption Value by Application (2018-2029)
    6.3 Global Prostacyclin Drug Average Price by Application (2018-2029)

7 North America
    7.1 North America Prostacyclin Drug Sales Quantity by Type (2018-2029)
    7.2 North America Prostacyclin Drug Sales Quantity by Application (2018-2029)
    7.3 North America Prostacyclin Drug Market Size by Country
        7.3.1 North America Prostacyclin Drug Sales Quantity by Country (2018-2029)
        7.3.2 North America Prostacyclin Drug Consumption Value by Country (2018-2029)
        7.3.3 United States Market Size and Forecast (2018-2029)
        7.3.4 Canada Market Size and Forecast (2018-2029)
        7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
    8.1 Europe Prostacyclin Drug Sales Quantity by Type (2018-2029)
    8.2 Europe Prostacyclin Drug Sales Quantity by Application (2018-2029)
    8.3 Europe Prostacyclin Drug Market Size by Country
        8.3.1 Europe Prostacyclin Drug Sales Quantity by Country (2018-2029)
        8.3.2 Europe Prostacyclin Drug Consumption Value by Country (2018-2029)
        8.3.3 Germany Market Size and Forecast (2018-2029)
        8.3.4 France Market Size and Forecast (2018-2029)
        8.3.5 United Kingdom Market Size and Forecast (2018-2029)
        8.3.6 Russia Market Size and Forecast (2018-2029)
        8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
    9.1 Asia-Pacific Prostacyclin Drug Sales Quantity by Type (2018-2029)
    9.2 Asia-Pacific Prostacyclin Drug Sales Quantity by Application (2018-2029)
    9.3 Asia-Pacific Prostacyclin Drug Market Size by Region
        9.3.1 Asia-Pacific Prostacyclin Drug Sales Quantity by Region (2018-2029)
        9.3.2 Asia-Pacific Prostacyclin Drug Consumption Value by Region (2018-2029)
        9.3.3 China Market Size and Forecast (2018-2029)
        9.3.4 Japan Market Size and Forecast (2018-2029)
        9.3.5 Korea Market Size and Forecast (2018-2029)
        9.3.6 India Market Size and Forecast (2018-2029)
        9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
        9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
    10.1 South America Prostacyclin Drug Sales Quantity by Type (2018-2029)
    10.2 South America Prostacyclin Drug Sales Quantity by Application (2018-2029)
    10.3 South America Prostacyclin Drug Market Size by Country
        10.3.1 South America Prostacyclin Drug Sales Quantity by Country (2018-2029)
        10.3.2 South America Prostacyclin Drug Consumption Value by Country (2018-2029)
        10.3.3 Brazil Market Size and Forecast (2018-2029)
        10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
    11.1 Middle East & Africa Prostacyclin Drug Sales Quantity by Type (2018-2029)
    11.2 Middle East & Africa Prostacyclin Drug Sales Quantity by Application (2018-2029)
    11.3 Middle East & Africa Prostacyclin Drug Market Size by Country
        11.3.1 Middle East & Africa Prostacyclin Drug Sales Quantity by Country (2018-2029)
        11.3.2 Middle East & Africa Prostacyclin Drug Consumption Value by Country (2018-2029)
        11.3.3 Turkey Market Size and Forecast (2018-2029)
        11.3.4 Egypt Market Size and Forecast (2018-2029)
        11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
        11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
    12.1 Prostacyclin Drug Market Drivers
    12.2 Prostacyclin Drug Market Restraints
    12.3 Prostacyclin Drug Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry
    12.5 Influence of COVID-19 and Russia-Ukraine War
        12.5.1 Influence of COVID-19
        12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain
    13.1 Raw Material of Prostacyclin Drug and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Prostacyclin Drug
    13.3 Prostacyclin Drug Production Process
    13.4 Prostacyclin Drug Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Prostacyclin Drug Typical Distributors
    14.3 Prostacyclin Drug Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Prostacyclin Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Prostacyclin Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. United Therapeutics Basic Information, Manufacturing Base and Competitors
    Table 4. United Therapeutics Major Business
    Table 5. United Therapeutics Prostacyclin Drug Product and Services
    Table 6. United Therapeutics Prostacyclin Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 7. United Therapeutics Recent Developments/Updates
    Table 8. Actelion (J & J) Basic Information, Manufacturing Base and Competitors
    Table 9. Actelion (J & J) Major Business
    Table 10. Actelion (J & J) Prostacyclin Drug Product and Services
    Table 11. Actelion (J & J) Prostacyclin Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 12. Actelion (J & J) Recent Developments/Updates
    Table 13. GSK Basic Information, Manufacturing Base and Competitors
    Table 14. GSK Major Business
    Table 15. GSK Prostacyclin Drug Product and Services
    Table 16. GSK Prostacyclin Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 17. GSK Recent Developments/Updates
    Table 18. Teva Basic Information, Manufacturing Base and Competitors
    Table 19. Teva Major Business
    Table 20. Teva Prostacyclin Drug Product and Services
    Table 21. Teva Prostacyclin Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 22. Teva Recent Developments/Updates
    Table 23. Toray Basic Information, Manufacturing Base and Competitors
    Table 24. Toray Major Business
    Table 25. Toray Prostacyclin Drug Product and Services
    Table 26. Toray Prostacyclin Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 27. Toray Recent Developments/Updates
    Table 28. Tide Pharma Basic Information, Manufacturing Base and Competitors
    Table 29. Tide Pharma Major Business
    Table 30. Tide Pharma Prostacyclin Drug Product and Services
    Table 31. Tide Pharma Prostacyclin Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 32. Tide Pharma Recent Developments/Updates
    Table 33. Bayer AG Basic Information, Manufacturing Base and Competitors
    Table 34. Bayer AG Major Business
    Table 35. Bayer AG Prostacyclin Drug Product and Services
    Table 36. Bayer AG Prostacyclin Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 37. Bayer AG Recent Developments/Updates
    Table 38. Global Prostacyclin Drug Sales Quantity by Manufacturer (2018-2023) & (K Units)
    Table 39. Global Prostacyclin Drug Revenue by Manufacturer (2018-2023) & (USD Million)
    Table 40. Global Prostacyclin Drug Average Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 41. Market Position of Manufacturers in Prostacyclin Drug, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
    Table 42. Head Office and Prostacyclin Drug Production Site of Key Manufacturer
    Table 43. Prostacyclin Drug Market: Company Product Type Footprint
    Table 44. Prostacyclin Drug Market: Company Product Application Footprint
    Table 45. Prostacyclin Drug New Market Entrants and Barriers to Market Entry
    Table 46. Prostacyclin Drug Mergers, Acquisition, Agreements, and Collaborations
    Table 47. Global Prostacyclin Drug Sales Quantity by Region (2018-2023) & (K Units)
    Table 48. Global Prostacyclin Drug Sales Quantity by Region (2024-2029) & (K Units)
    Table 49. Global Prostacyclin Drug Consumption Value by Region (2018-2023) & (USD Million)
    Table 50. Global Prostacyclin Drug Consumption Value by Region (2024-2029) & (USD Million)
    Table 51. Global Prostacyclin Drug Average Price by Region (2018-2023) & (US$/Unit)
    Table 52. Global Prostacyclin Drug Average Price by Region (2024-2029) & (US$/Unit)
    Table 53. Global Prostacyclin Drug Sales Quantity by Type (2018-2023) & (K Units)
    Table 54. Global Prostacyclin Drug Sales Quantity by Type (2024-2029) & (K Units)
    Table 55. Global Prostacyclin Drug Consumption Value by Type (2018-2023) & (USD Million)
    Table 56. Global Prostacyclin Drug Consumption Value by Type (2024-2029) & (USD Million)
    Table 57. Global Prostacyclin Drug Average Price by Type (2018-2023) & (US$/Unit)
    Table 58. Global Prostacyclin Drug Average Price by Type (2024-2029) & (US$/Unit)
    Table 59. Global Prostacyclin Drug Sales Quantity by Application (2018-2023) & (K Units)
    Table 60. Global Prostacyclin Drug Sales Quantity by Application (2024-2029) & (K Units)
    Table 61. Global Prostacyclin Drug Consumption Value by Application (2018-2023) & (USD Million)
    Table 62. Global Prostacyclin Drug Consumption Value by Application (2024-2029) & (USD Million)
    Table 63. Global Prostacyclin Drug Average Price by Application (2018-2023) & (US$/Unit)
    Table 64. Global Prostacyclin Drug Average Price by Application (2024-2029) & (US$/Unit)
    Table 65. North America Prostacyclin Drug Sales Quantity by Type (2018-2023) & (K Units)
    Table 66. North America Prostacyclin Drug Sales Quantity by Type (2024-2029) & (K Units)
    Table 67. North America Prostacyclin Drug Sales Quantity by Application (2018-2023) & (K Units)
    Table 68. North America Prostacyclin Drug Sales Quantity by Application (2024-2029) & (K Units)
    Table 69. North America Prostacyclin Drug Sales Quantity by Country (2018-2023) & (K Units)
    Table 70. North America Prostacyclin Drug Sales Quantity by Country (2024-2029) & (K Units)
    Table 71. North America Prostacyclin Drug Consumption Value by Country (2018-2023) & (USD Million)
    Table 72. North America Prostacyclin Drug Consumption Value by Country (2024-2029) & (USD Million)
    Table 73. Europe Prostacyclin Drug Sales Quantity by Type (2018-2023) & (K Units)
    Table 74. Europe Prostacyclin Drug Sales Quantity by Type (2024-2029) & (K Units)
    Table 75. Europe Prostacyclin Drug Sales Quantity by Application (2018-2023) & (K Units)
    Table 76. Europe Prostacyclin Drug Sales Quantity by Application (2024-2029) & (K Units)
    Table 77. Europe Prostacyclin Drug Sales Quantity by Country (2018-2023) & (K Units)
    Table 78. Europe Prostacyclin Drug Sales Quantity by Country (2024-2029) & (K Units)
    Table 79. Europe Prostacyclin Drug Consumption Value by Country (2018-2023) & (USD Million)
    Table 80. Europe Prostacyclin Drug Consumption Value by Country (2024-2029) & (USD Million)
    Table 81. Asia-Pacific Prostacyclin Drug Sales Quantity by Type (2018-2023) & (K Units)
    Table 82. Asia-Pacific Prostacyclin Drug Sales Quantity by Type (2024-2029) & (K Units)
    Table 83. Asia-Pacific Prostacyclin Drug Sales Quantity by Application (2018-2023) & (K Units)
    Table 84. Asia-Pacific Prostacyclin Drug Sales Quantity by Application (2024-2029) & (K Units)
    Table 85. Asia-Pacific Prostacyclin Drug Sales Quantity by Region (2018-2023) & (K Units)
    Table 86. Asia-Pacific Prostacyclin Drug Sales Quantity by Region (2024-2029) & (K Units)
    Table 87. Asia-Pacific Prostacyclin Drug Consumption Value by Region (2018-2023) & (USD Million)
    Table 88. Asia-Pacific Prostacyclin Drug Consumption Value by Region (2024-2029) & (USD Million)
    Table 89. South America Prostacyclin Drug Sales Quantity by Type (2018-2023) & (K Units)
    Table 90. South America Prostacyclin Drug Sales Quantity by Type (2024-2029) & (K Units)
    Table 91. South America Prostacyclin Drug Sales Quantity by Application (2018-2023) & (K Units)
    Table 92. South America Prostacyclin Drug Sales Quantity by Application (2024-2029) & (K Units)
    Table 93. South America Prostacyclin Drug Sales Quantity by Country (2018-2023) & (K Units)
    Table 94. South America Prostacyclin Drug Sales Quantity by Country (2024-2029) & (K Units)
    Table 95. South America Prostacyclin Drug Consumption Value by Country (2018-2023) & (USD Million)
    Table 96. South America Prostacyclin Drug Consumption Value by Country (2024-2029) & (USD Million)
    Table 97. Middle East & Africa Prostacyclin Drug Sales Quantity by Type (2018-2023) & (K Units)
    Table 98. Middle East & Africa Prostacyclin Drug Sales Quantity by Type (2024-2029) & (K Units)
    Table 99. Middle East & Africa Prostacyclin Drug Sales Quantity by Application (2018-2023) & (K Units)
    Table 100. Middle East & Africa Prostacyclin Drug Sales Quantity by Application (2024-2029) & (K Units)
    Table 101. Middle East & Africa Prostacyclin Drug Sales Quantity by Region (2018-2023) & (K Units)
    Table 102. Middle East & Africa Prostacyclin Drug Sales Quantity by Region (2024-2029) & (K Units)
    Table 103. Middle East & Africa Prostacyclin Drug Consumption Value by Region (2018-2023) & (USD Million)
    Table 104. Middle East & Africa Prostacyclin Drug Consumption Value by Region (2024-2029) & (USD Million)
    Table 105. Prostacyclin Drug Raw Material
    Table 106. Key Manufacturers of Prostacyclin Drug Raw Materials
    Table 107. Prostacyclin Drug Typical Distributors
    Table 108. Prostacyclin Drug Typical Customers
List of Figures
    Figure 1. Prostacyclin Drug Picture
    Figure 2. Global Prostacyclin Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Prostacyclin Drug Consumption Value Market Share by Type in 2022
    Figure 4. Epoprostenol Sodium Examples
    Figure 5. Treprostinil Examples
    Figure 6. Iloprost Examples
    Figure 7. Beraprost Sodium Examples
    Figure 8. Global Prostacyclin Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 9. Global Prostacyclin Drug Consumption Value Market Share by Application in 2022
    Figure 10. For Injection Examples
    Figure 11. For Oral Examples
    Figure 12. For Inhalation Examples
    Figure 13. Global Prostacyclin Drug Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 14. Global Prostacyclin Drug Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 15. Global Prostacyclin Drug Sales Quantity (2018-2029) & (K Units)
    Figure 16. Global Prostacyclin Drug Average Price (2018-2029) & (US$/Unit)
    Figure 17. Global Prostacyclin Drug Sales Quantity Market Share by Manufacturer in 2022
    Figure 18. Global Prostacyclin Drug Consumption Value Market Share by Manufacturer in 2022
    Figure 19. Producer Shipments of Prostacyclin Drug by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
    Figure 20. Top 3 Prostacyclin Drug Manufacturer (Consumption Value) Market Share in 2022
    Figure 21. Top 6 Prostacyclin Drug Manufacturer (Consumption Value) Market Share in 2022
    Figure 22. Global Prostacyclin Drug Sales Quantity Market Share by Region (2018-2029)
    Figure 23. Global Prostacyclin Drug Consumption Value Market Share by Region (2018-2029)
    Figure 24. North America Prostacyclin Drug Consumption Value (2018-2029) & (USD Million)
    Figure 25. Europe Prostacyclin Drug Consumption Value (2018-2029) & (USD Million)
    Figure 26. Asia-Pacific Prostacyclin Drug Consumption Value (2018-2029) & (USD Million)
    Figure 27. South America Prostacyclin Drug Consumption Value (2018-2029) & (USD Million)
    Figure 28. Middle East & Africa Prostacyclin Drug Consumption Value (2018-2029) & (USD Million)
    Figure 29. Global Prostacyclin Drug Sales Quantity Market Share by Type (2018-2029)
    Figure 30. Global Prostacyclin Drug Consumption Value Market Share by Type (2018-2029)
    Figure 31. Global Prostacyclin Drug Average Price by Type (2018-2029) & (US$/Unit)
    Figure 32. Global Prostacyclin Drug Sales Quantity Market Share by Application (2018-2029)
    Figure 33. Global Prostacyclin Drug Consumption Value Market Share by Application (2018-2029)
    Figure 34. Global Prostacyclin Drug Average Price by Application (2018-2029) & (US$/Unit)
    Figure 35. North America Prostacyclin Drug Sales Quantity Market Share by Type (2018-2029)
    Figure 36. North America Prostacyclin Drug Sales Quantity Market Share by Application (2018-2029)
    Figure 37. North America Prostacyclin Drug Sales Quantity Market Share by Country (2018-2029)
    Figure 38. North America Prostacyclin Drug Consumption Value Market Share by Country (2018-2029)
    Figure 39. United States Prostacyclin Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 40. Canada Prostacyclin Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 41. Mexico Prostacyclin Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 42. Europe Prostacyclin Drug Sales Quantity Market Share by Type (2018-2029)
    Figure 43. Europe Prostacyclin Drug Sales Quantity Market Share by Application (2018-2029)
    Figure 44. Europe Prostacyclin Drug Sales Quantity Market Share by Country (2018-2029)
    Figure 45. Europe Prostacyclin Drug Consumption Value Market Share by Country (2018-2029)
    Figure 46. Germany Prostacyclin Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 47. France Prostacyclin Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 48. United Kingdom Prostacyclin Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 49. Russia Prostacyclin Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 50. Italy Prostacyclin Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 51. Asia-Pacific Prostacyclin Drug Sales Quantity Market Share by Type (2018-2029)
    Figure 52. Asia-Pacific Prostacyclin Drug Sales Quantity Market Share by Application (2018-2029)
    Figure 53. Asia-Pacific Prostacyclin Drug Sales Quantity Market Share by Region (2018-2029)
    Figure 54. Asia-Pacific Prostacyclin Drug Consumption Value Market Share by Region (2018-2029)
    Figure 55. China Prostacyclin Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 56. Japan Prostacyclin Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 57. Korea Prostacyclin Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 58. India Prostacyclin Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 59. Southeast Asia Prostacyclin Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 60. Australia Prostacyclin Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 61. South America Prostacyclin Drug Sales Quantity Market Share by Type (2018-2029)
    Figure 62. South America Prostacyclin Drug Sales Quantity Market Share by Application (2018-2029)
    Figure 63. South America Prostacyclin Drug Sales Quantity Market Share by Country (2018-2029)
    Figure 64. South America Prostacyclin Drug Consumption Value Market Share by Country (2018-2029)
    Figure 65. Brazil Prostacyclin Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 66. Argentina Prostacyclin Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 67. Middle East & Africa Prostacyclin Drug Sales Quantity Market Share by Type (2018-2029)
    Figure 68. Middle East & Africa Prostacyclin Drug Sales Quantity Market Share by Application (2018-2029)
    Figure 69. Middle East & Africa Prostacyclin Drug Sales Quantity Market Share by Region (2018-2029)
    Figure 70. Middle East & Africa Prostacyclin Drug Consumption Value Market Share by Region (2018-2029)
    Figure 71. Turkey Prostacyclin Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 72. Egypt Prostacyclin Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 73. Saudi Arabia Prostacyclin Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 74. South Africa Prostacyclin Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 75. Prostacyclin Drug Market Drivers
    Figure 76. Prostacyclin Drug Market Restraints
    Figure 77. Prostacyclin Drug Market Trends
    Figure 78. Porters Five Forces Analysis
    Figure 79. Manufacturing Cost Structure Analysis of Prostacyclin Drug in 2022
    Figure 80. Manufacturing Process Analysis of Prostacyclin Drug
    Figure 81. Prostacyclin Drug Industrial Chain
    Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 83. Direct Channel Pros & Cons
    Figure 84. Indirect Channel Pros & Cons
    Figure 85. Methodology
    Figure 86. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

United Therapeutics
Actelion (J & J)
GSK
Teva
Toray
Tide Pharma
Bayer AG

Related Reports

Global Prostacyclin Drug Supply, Demand and Key Producers, 2023-2029

Global Prostacyclin Drug Supply, Demand and Key Producers, 2023-2029

date 25 Feb 2023

date Pharma & Healthcare

The global Prostacyclin Drug market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Prostacyclin Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Prostacyclin Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 09 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Prostacyclin Drug market size was valued at USD 2435.5 million in 2023 and is forecast to a readjusted size of USD 3168.1 million by 2030 with a CAGR of 3.8% during review period.

Global Prostacyclin Drug Supply, Demand and Key Producers, 2024-2030

Global Prostacyclin Drug Supply, Demand and Key Producers, 2024-2030

date 18 Feb 2024

date Pharma & Healthcare

The global Prostacyclin Drug market size is expected to reach $ 3168.1 million by 2030, rising at a market growth of 3.8% CAGR during the forecast period (2024-2030).

Product Tags

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>